« Return to News | CROs/Service Providers | Technology Solutions

Ignite Health acquires Syndicated Methods

Monday, August 22, 2011 12:15 PM

Ignite Health, an inVentiv Health company, has acquired Syndicated Methods, a San Diego-based mobile development firm. The acquisition rapidly expands Ignite Health's digital leadership into the exploding mobile health space.

"This acquisition allows Ignite Health to immediately absorb the technology, talent and years of mobile development experience that will turbocharge our ability to deliver cutting-edge mobile solutions in the healthcare space," said Matt Brown, Ignite Health president.

Ignite Health will also acquire an innovative technology called MobilePipes, an enterprise software framework that allows developers to quickly create, track and manage mobile software services and application integrations across multiple devices.

"Smartphone and tablet devices are completely transforming the way people interact with healthcare information and brands," said Fabio Gratton, Ignite co-founder and chief innovation officer. "The transformation has been so significant that Ignite Health is now developing strategies and building campaigns through a customer-centered, mobile-first lens."

According to market research firm Parks Associates, U.S. revenues from digital health technology solutions are expected to grow by more than 27% between 2010 and 2015 to $5.7 billion, driven primarily by growth in mobile.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.